File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Evidence-based point-of-care diagnostics: Current status and emerging technologies

TitleEvidence-based point-of-care diagnostics: Current status and emerging technologies
Authors
Chan, Cangel Pui YeeMak, Wing CheungCheung, Kwan YeeSin, King KeungYu, Cheuk ManRainer, Timothy H.Renneberg, Reinhard
Keywordsmicrofluidics
heart failure
tuberculosis
acute coronary syndrome
POC
human immunodeficiency virus
Issue Date2013
Citation
Annual Review of Analytical Chemistry, 2013, v. 6, p. 191-211 How to Cite?
DOI: http://dx.doi.org/10.1146/annurev-anchem-062012-092641
AbstractPoint-of-care (POC) diagnostics brings tests nearer to the site of patient care. The turnaround time is short, and minimal manual interference enables quick clinical management decisions. Growth in POC diagnostics is being continuously fueled by the global burden of cardiovascular and infectious diseases. Early diagnosis and rapid initiation of treatment are crucial in the management of such patients. This review provides the rationale for the use of POC tests in acute coronary syndrome, heart failure, human immunodeficiency virus, and tuberculosis. We also consider emerging technologies that are based on advanced nanomaterials and microfluidics, improved assay sensitivity, miniaturization in device design, reduced costs, and high-throughput multiplex detection, all of which may shape the future development of POC diagnostics. Copyright © 2013 by Annual Reviews.
Persistent Identifierhttp://hdl.handle.net/10722/292233
ISSN
1936-1327
2023 Impact Factor: 5.9
2023 SCImago Journal Rankings: 1.571
ISI Accession Number ID
WOS:000323887500010

 

DC FieldValueLanguage
dc.contributor.authorChan, Cangel Pui Yee-
dc.contributor.authorMak, Wing Cheung-
dc.contributor.authorCheung, Kwan Yee-
dc.contributor.authorSin, King Keung-
dc.contributor.authorYu, Cheuk Man-
dc.contributor.authorRainer, Timothy H.-
dc.contributor.authorRenneberg, Reinhard-
dc.date.accessioned2020-11-17T14:56:02Z-
dc.date.available2020-11-17T14:56:02Z-
dc.date.issued2013-
dc.identifier.citationAnnual Review of Analytical Chemistry, 2013, v. 6, p. 191-211-
dc.identifier.issn1936-1327-
dc.identifier.urihttp://hdl.handle.net/10722/292233-
dc.description.abstractPoint-of-care (POC) diagnostics brings tests nearer to the site of patient care. The turnaround time is short, and minimal manual interference enables quick clinical management decisions. Growth in POC diagnostics is being continuously fueled by the global burden of cardiovascular and infectious diseases. Early diagnosis and rapid initiation of treatment are crucial in the management of such patients. This review provides the rationale for the use of POC tests in acute coronary syndrome, heart failure, human immunodeficiency virus, and tuberculosis. We also consider emerging technologies that are based on advanced nanomaterials and microfluidics, improved assay sensitivity, miniaturization in device design, reduced costs, and high-throughput multiplex detection, all of which may shape the future development of POC diagnostics. Copyright © 2013 by Annual Reviews.-
dc.languageeng-
dc.relation.ispartofAnnual Review of Analytical Chemistry-
dc.subjectmicrofluidics-
dc.subjectheart failure-
dc.subjecttuberculosis-
dc.subjectacute coronary syndrome-
dc.subjectPOC-
dc.subjecthuman immunodeficiency virus-
dc.titleEvidence-based point-of-care diagnostics: Current status and emerging technologies-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1146/annurev-anchem-062012-092641-
dc.identifier.pmid23527548-
dc.identifier.scopuseid_2-s2.0-84879672740-
dc.identifier.volume6-
dc.identifier.spage191-
dc.identifier.epage211-
dc.identifier.eissn1936-1335-
dc.identifier.isiWOS:000323887500010-
dc.identifier.issnl1936-1327-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats